Trial intelligence / Profile preview

Neurotropin for Chronic Neuropathic Pain (CRPS)

NCT00006289Phase 2Terminated

Sponsor
National Institute of Nursing Research
Start
Sep 2000
Primary completion
Jun 2012
Modality
Biologic
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of vaccinia virus-inoculated rabbit skin extract in complex regional pain syndrome type I (CRPS) and Complex regional pain syndrome type 2 (2 arms), sponsored by National Institute of Nursing Research. Primary endpoints: Visual Analogue Scale of Pain Scores at 5 weeks, Numeric Rating Scale of Pain Scores at 5 weeks and 1 more. Started Sep 2000; status: terminated.

02

Drugs

vaccinia virus-inoculated rabbit skin extract
03

Conditions

complex regional pain syndrome type I (CRPS)Complex regional pain syndrome type 2

Beyond the preview

Go deeper on NCT00006289.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006289.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call